Clinical Trial Update: A Pilot Study of Suvorexant for Insomnia in Parkinson Disease [Phase 4]

View source ↗

Summary

Phase 4 pilot study evaluating suvorexant for insomnia in Parkinson's disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia
• Parkinson Disease

Drugs mentioned

• Suvorexant (suvorexant)

Snippet

Sponsor: Burdick, Daniel, M.D. | Conditions: Insomnia | Phase 4 | Status: COMPLETED | Results posted: 2024-08-20